Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

  1. Lopez-Anglada, L.
  2. Cueto-Felgueroso, C.
  3. Rosiñol, L.
  4. Oriol, A.
  5. Teruel, A.I.
  6. Lopez de la Guia, A.
  7. Bengoechea, E.
  8. Palomera, L.
  9. de Arriba, F.
  10. Hernandez, J.M.
  11. Granell, M.
  12. Peñalver, F.J.
  13. Garcia-Sanz, R.
  14. Besalduch, J.
  15. Gonzalez, Y.
  16. Martinez, R.B.
  17. Hernandez, M.T.
  18. Gutierrez, N.C.
  19. Puerta, P.
  20. Valeri, A.
  21. Paiva, B.
  22. Blade, J.
  23. Mateos, M.-V.
  24. Miguel, J.S.
  25. Lahuerta, J.J.
  26. Martinez-Lopez, J.
  27. Erakutsi egile guztiak +
Aldizkaria:
PLoS ONE

ISSN: 1932-6203

Argitalpen urtea: 2018

Alea: 13

Zenbakia: 9

Mota: Artikulua

DOI: 10.1371/JOURNAL.PONE.0203392 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak